Market By Application, Modality And Country | Forecast 2019-2028
According to an analysis by Triton Market Research, the extra corporeal membrane oxygenation (ECMO) system market in North America is likely to augment at a CAGR of 4.85% over the forthcoming period between 2019 and 2028.
Report scope can be customized per your requirements. Request For Customization
The countries evaluated in the North American extra corporeal membrane oxygenation (ECMO) system market are:
• Canada
• The United States
In 2017, about 7.9% of the total population in the United States suffered from asthma. According to the global asthma network 2018 report, the overall annual asthma costs in the US increased from $60 billion to $64 billion between the years 2002 and 2011, thereby exerting an economic burden in the country. It is reported that, in 2018, the direct costs per patient per year in the US was over $3000. The alarming increase in the death rates associated with asthma and the growing investment towards the development of asthma treatment are anticipated to fuel demand for extra corporeal membrane oxygenation (ECMO) systems in the US in the upcoming years.
Asthma, a lifelong respiratory illness, is one of the significant health concerns in Canada. This disease is affecting different aspects of life, including quality of life, work productivity, psychological wellbeing and mental health of the public. Reportedly, the country had more than 3.8 million cases of asthma in 2019. Extra corporeal membrane oxygenation (ECMO) systems are expected to provide proper gas exchange at times of acute respiratory failure. The high incidence of asthma in the country and the ever-increasing adoption of ECMO systems are estimated to flourish the market growth over the projected period.
Established in 1997, OriGen Biomedical Inc is a medical device manufacturing company. It manufactures different products to treat genetic conditions, cancer, respiratory distress and other life-threatening diseases. The company strives to maintain excellent customer service to retain its position in the market. The FloPump 32 Centrifugal Pump is an extracorporeal circuit pump for surgeries to provide full or partial cardiopulmonary bypass. It is headquartered in Austin, Texas.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
1. NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1.MARKET DEFINITION
2.2.PORTER’S FIVE FORCES MODEL
2.2.1.THREAT OF NEW ENTRANTS
2.2.2.THREAT OF SUBSTITUTE PRODUCTS
2.2.3.BARGAINING POWER OF BUYERS
2.2.4.BARGAINING POWER OF SUPPLIERS
2.2.5.COMPETITIVE RIVALRY
2.3.IMPACT OF COVID-19 ON ECMO SYSTEM MARKET
2.4.MARKET ATTRACTIVENESS INDEX
2.5.VENDOR SCORECARD
2.6.KEY INSIGHTS
2.7.MARKET DRIVERS
2.7.1.RISING POPULARITY OF ECMO TECHNOLOGY
2.7.2.INCREASING PREVALENCE OF CHRONIC DISORDERS
2.8.MARKET RESTRAINTS
2.8.1.SIGNIFICANT COST OF ECMO SYSTEMS
2.8.2.EXISTENCE OF ALTERNATIVE TECHNIQUES
2.9.MARKET OPPORTUNITIES
2.9.1.GROWING AWARENESS REGARDING APPLICATIONS OF ECMO SYSTEMS
2.9.2.ADVANCEMENT IN TECHNOLOGY
2.10.MARKET CHALLENGES
2.10.1.LACK OF SPECIALIZED SKILLS FOR OPERATION
2.10.2.RISKS ASSOCIATED WITH ECMO PROCEDURES
3. EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET OUTLOOK - BY APPLICATION
3.1.RESPIRATORY
3.2.CARDIAC
3.3.EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)
4. EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET OUTLOOK - BY MODALITY
4.1.VENO-VENOUS
4.2.VENO-ARTERIAL
4.3.OTHER MODALITIES
5. EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET – NORTH AMERICA
5.1.UNITED STATES
5.2.CANADA
6. COMPANY PROFILES
6.1.HEMOVENT GMBH
6.2.LIVANOVA PLC
6.3.MICROPORT SCIENTIFIC CORPORATION
6.4.TERUMO MEDICAL CORPORATION
6.5.ELSIUS BIOMEDICAL INC
6.6.ABBOTT LABORATORIES
6.7.ALUNG TECHNOLOGIES INC
6.8.EUROSETS
6.9.SPECTRUM MEDICAL
6.10.XENIOS AG (FRESENIUS SE & CO KGAA)
6.11.MEDTRONIC PLC
6.12.GETINGE AB
6.13.NIPRO CORPORATION
6.14.ORIGEN BIOMEDICAL INC
7. RESEARCH METHODOLOGY & SCOPE
7.1.RESEARCH SCOPE & DELIVERABLES
7.1.1.OBJECTIVES OF STUDY
7.1.2.SCOPE OF STUDY
7.2.SOURCES OF DATA
7.2.1.PRIMARY DATA SOURCES
7.2.2.SECONDARY DATA SOURCES
7.3.RESEARCH METHODOLOGY
7.3.1.EVALUATION OF PROPOSED MARKET
7.3.2.IDENTIFICATION OF DATA SOURCES
7.3.3.ASSESSMENT OF MARKET DETERMINANTS
7.3.4.DATA COLLECTION
7.3.5.DATA VALIDATION & ANALYSIS
TABLE 1 NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, 2019-2028 ($ MILLION)
TABLE 2 VENDOR SCORECARD
TABLE 3 NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, 2019-2028 ($ MILLION)
TABLE 4 NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, 2019-2028 ($ MILLION)
TABLE 5 NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, 2019-2028 ($ MILLION)
FIGURE 1 NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)
FIGURE 2 LIST OF CHRONIC DISEASES
FIGURE 3 NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY RESPIRATORY, 2019-2028 ($ MILLION)
FIGURE 4 NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY CARDIAC, 2019-2028 ($ MILLION)
FIGURE 5 NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR), 2019-2028 ($ MILLION)
FIGURE 6 NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY VENO-VENOUS, 2019-2028 ($ MILLION)
FIGURE 7 NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY VENO-ARTERIAL, 2019-2028 ($ MILLION)
FIGURE 8 NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY OTHER MODALITIES, 2019-2028 ($ MILLION)
FIGURE 9 UNITED STATES EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)
FIGURE 10 CANADA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)